Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Pharma-bio Serv Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Pharma-bio Serv Inc (PBSV) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
19.00 %
Q3 2026
Net Margin
-3.07 %
Q3 2026

Key Findings: Pharma-bio Serv Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 9M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is holding steady (-1.5% annualized vs trailing 12 months).
  • Peer revenue share: Pharma-bio Serv Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PBSV Sales vs. its Competitors, Q3 2026

Pharma-bio Serv Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/PBSV/competitors
https://api.csimarket.com/api/v1/companies/PBSV/relationships
https://api.csimarket.com/api/v1/companies/PBSV/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Consulting Services industry grew revenue 7.1% year over year, combined, vs 19.0% for Pharma-bio Serv Inc. Pharma-bio Serv Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.

Pharma-bio Serv Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Pharma-Bio Serv, Inc. Yes Yes No -
Similar Growth & Profitability (8) 50.00 % (4 of 8) 62.50 % (5 of 8) 62.50 % (5 of 8) 14.30 % (1 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2026

100%market share
  • Pharma-bio Serv Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Pharma-bio Serv Inc and its 0 tracked competitors.

See Pharma-bio Serv Inc's full market share breakdown »

PBSV Stock Performance relative to its Competitors

PBSV Competitors (weighted) Percent change over the selected range

PBSV Stock Performance relative to Similar Growth & Profitability Competitors

PBSV Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Pharma-bio Serv Inc's Comment on Competition and Industry Peers

The company operates in a competitive and fragmented consulting industry characterized by numerous competitors, including larger firms and subsidiaries with greater resources. The industry’s low capital requirements facilitate entry for new qualified firms. Competition occurs at regional, national, and international levels, with some local competitors having better client access. The company has over 30 years of market presence in Puerto Rico, a strong brand name, and a track record with major pharmaceutical, biotechnology, medical device, and chemical manufacturing companies. It offers services at competitive prices. The market for qualified technical consultants is highly competitive and includes both consulting firms and companies within the pharmaceutical, chemical, biotechnology, and medical device sectors, some of which are clients or potential clients. The company utilizes its name recognition, reputation, and compensation packages to attract qualified personnel.